KeraStat® Gel with Morphine for Painful Open Wounds
This study is testing KeraStat® Gel with Morphine to see if it can reduce pain in people with non-healing, painful open wounds and ulcers. Researchers want to see if applying this gel directly to the wound can lower daily pain levels, reduce pain during dressing changes, and decrease the need for other pain medications. You might be able to join if you are 18 or older, have a painful open wound between 1 and 300 square centimeters, and have a minimum pain level of 2 on a pain scale. The study will measure changes in your pain levels and any side effects over 12 weeks to see how well the gel works.
- Study design
- This is an interventional study planning to enroll 24 participants. It compares KeraStat® Gel with Morphine to KeraStat® Gel alone.
- What's involved
- You would have KeraStat® Gel applied every two weeks for up to 12 weeks. You would also apply the gel at home every 1-3 days and change dressings.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your pain levels and adverse events will be assessed for up to 12 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Pilot Study: KeraStat® Gel for Topical Delivery of Morphine for Management of Non-Healing, Painful Open Wounds and Ulcers
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Change in Visual Analog ScaleDay 0 and Every 2 weeks for up to 12 weeks
This unidimensional measure is composed of a line, usually 10 centimeters in length, anchored by two verbal descriptors representing the symptom extremes ("no pain" and "worst imaginable pain") and 6 facial expression anchors.
- Change in Adverse event assessmentDay 0 and Every 2 weeks for up to 12 weeks
Assessment of adverse events throughout the course of the subject treatment.